{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:28Z","timestamp":1791907288289,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Idiopathic normal pressure hydrocephalus (iNPH) is a potentially reversible cause of dementia and gait disturbance that is typically treated by operative placement of a ventriculoperitoneal shunt. The outcome from shunting is variable, and some evidence suggests that the presence of comorbid Alzheimer's disease (AD) may impact shunt outcome. Evidence also suggests that AD biomarkers in cerebrospinal fluid (CSF) may predict the presence of AD. The aim of this study was to investigate the relationship between the phosphorylated tau\/amyloid beta 1-42 (ptau\/A\u03b21-42) ratio in ventricular CSF and shunt outcome in patients with iNPH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a prospective trial with a cohort of 39 patients with suspected iNPH. Patients were clinically and psychometrically assessed prior to and approximately 4 months after ventriculoperitoneal shunting. Lumbar and ventricular CSF obtained intraoperatively, and tissue from intraoperative cortical biopsies were analyzed for AD biomarkers. Outcome measures included performance on clinical symptom scales, supplementary gait measures, and standard psychometric tests. We investigated relationships between the ptau\/A\u03b21-42 ratio in ventricular CSF and cortical AD pathology, initial clinical features, shunt outcome, and lumbar CSF ptau\/A\u03b21-42 ratios in the patients in our cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that high ptau\/A\u03b21-42 ratios in ventricular CSF correlated with the presence of cortical AD pathology. At baseline, iNPH patients with ratio values most suggestive of AD presented with better gait performance but poorer cognitive performance. Patients with high ptau\/A\u03b21-42 ratios also showed a less robust response to shunting on both gait and cognitive measures. Finally, in a subset of 18 patients who also underwent lumbar puncture, ventricular CSF ratios were significantly correlated with lumbar CSF ratios.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Levels of AD biomarkers in CSF correlate with the presence of cortical AD pathology and predict aspects of clinical presentation in iNPH. Moreover, preliminary evidence suggests that CSF biomarkers of AD may prove useful for stratifying shunt prognosis in patients being evaluated and treated for this condition.<\/jats:p><\/jats:sec>","DOI":"10.1186\/2045-8118-9-7","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T06:10:20Z","timestamp":1332569420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Phosphorylated tau\/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus"],"prefix":"10.1186","volume":"9","author":[{"given":"Sunil","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anica","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Sean","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy H","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"34_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ana.22015","volume":"68","author":"R Hamilton","year":"2010","unstructured":"Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ: Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol. 2010, 68: 535-540. 10.1002\/ana.22015.","journal-title":"Ann Neurol"},{"key":"34_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","volume":"68","author":"J Golomb","year":"2000","unstructured":"Golomb J, Wisoff J, Miller DC, Boksay I, Kluger A, Weiner H, Salton J, Graves W: Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry. 2000, 68: 778-781. 10.1136\/jnnp.68.6.778.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s007010050353","volume":"141","author":"RA Bech","year":"1999","unstructured":"Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M: Shunting effects in patients with idiopathic normal pressure hydrocephalus: correlation with cerebral and leptomeningeal biopsy findings. Acta Neurochir (Wien). 1999, 141: 633-639. 10.1007\/s007010050353.","journal-title":"Acta Neurochir (Wien)"},{"key":"34_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jnnp.2006.095117","volume":"78","author":"R Bech-Azeddine","year":"2007","unstructured":"Bech-Azeddine R, Hogh P, Juhler M, Gjerris F, Waldemar G: Idiopathic normal pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry. 2007, 78: 157-161. 10.1136\/jnnp.2006.095117.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"L Shaw","year":"2009","unstructured":"Shaw L, Vanderstichele H, Knapik-czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ: CSF biomarker signature in AD neuroimaging initiative subjects. Ann Neurol. 2009, 65: 403-413. 10.1002\/ana.21610.","journal-title":"Ann Neurol"},{"key":"34_CR6","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","volume":"60","author":"CM Clark","year":"2003","unstructured":"Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarti C, Leight S, Lee VM, Trojanowski JQ: Cerebrospinal fluid tau and beta amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?. Arch Neurol. 2003, 60: 1696-1702. 10.1001\/archneur.60.12.1696.","journal-title":"Arch Neurol"},{"key":"34_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archneurpsyc.1942.02290060069004","volume":"47","author":"WA Evans","year":"1942","unstructured":"Evans WA: An encephalographic ratio for estimating ventricular and cerebral atrophy. Arch Neurol Psych. 1942, 47: 931-937.","journal-title":"Arch Neurol Psych"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF01402454","volume":"112","author":"J Sahuquillo","year":"1991","unstructured":"Sahuquillo J, Rubio E, Codina A, Molins A, Guitart JM, Poca MA, Chasampi A: Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called \"normal pressure hydrocephalus\" syndrome. Acta Neurochir (Wien). 1991, 112: 50-61. 10.1007\/BF01402454.","journal-title":"Acta Neurochir (Wien)"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ptj\/64.1.35","volume":"64","author":"MK Holden","year":"1984","unstructured":"Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L: Clinical gait assessment in the neurologically impaired: reliability and meaningfulness. Phys Ther. 1984, 64: 35-40.","journal-title":"Phys Ther"},{"key":"34_CR10","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1074\/jbc.M210105200","volume":"278","author":"EB Lee","year":"2003","unstructured":"Lee EB, Skovronsky DM, Abtahian F, Doms RW, Lee VM: Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neurons. J Biol Chem. 2003, 278: 4458-4466. 10.1074\/jbc.M210105200.","journal-title":"J Biol Chem"},{"key":"34_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jnr.490390607","volume":"39","author":"L Otvos Jr","year":"1994","unstructured":"Otvos L, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM: Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res. 1994, 39: 669-673. 10.1002\/jnr.490390607.","journal-title":"J Neurosci Res"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ana.10279","volume":"52","author":"JE Duda","year":"2002","unstructured":"Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ: Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol. 2002, 52: 205-210. 10.1002\/ana.10279.","journal-title":"Ann Neurol"},{"key":"34_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M: Concomitant TAR-DNA binding protein 43 pathology is present in Alzheimer's disease and corticobasal degeneration but not in other tauopathies. J Neuropath Exper Neurol. 2008, 67: 555-564. 10.1097\/NEN.0b013e31817713b5.","journal-title":"J Neuropath Exper Neurol"},{"key":"34_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991, 41: 479-486.","journal-title":"Neurology"},{"key":"34_CR15","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The statistical evaluation of medical tests for classification and prediction","author":"MS Pepe","year":"2003","unstructured":"Pepe MS: The statistical evaluation of medical tests for classification and prediction. 2003, NY, Oxford University Press: New York"},{"key":"34_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0447.1982.tb00827.x","volume":"65","author":"C Caltagirone","year":"1982","unstructured":"Caltagirone C, Gainotti G, Masullo C, Villa G: Neurophysiological study of normal pressure hydrocephalus. Acta Psychiatr Scand. 1982, 65: 93-100. 10.1111\/j.1600-0447.1982.tb00827.x.","journal-title":"Acta Psychiatr Scand"},{"key":"34_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1076\/1385-4046(200008)14:3;1-P;FT295","volume":"14","author":"G Tremont","year":"2000","unstructured":"Tremont G, Halpert S, Javorsky DJ, Stern RA: Differential impact of executive dysfunction on verbal list learning and story recall. Clin Neuropsychol. 2000, 14: 295-302. 10.1076\/1385-4046(200008)14:3;1-P;FT295.","journal-title":"Clin Neuropsychol"},{"key":"34_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","volume":"14","author":"EN Kapaki","year":"2007","unstructured":"Kapaki EN, Paraskevas GP, Tzerakis NG, Sfagos C, Seretis A, Kararizou E, Vassilopoulos D: Cerebrospinal fluid tau, phospho-tau181, and betaamyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur J Neurol. 2007, 14: 168-173. 10.1111\/j.1468-1331.2006.01593.x.","journal-title":"Eur J Neurol"},{"key":"34_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1351-5101.2003.00698.x","volume":"11","author":"M Tisell","year":"2004","unstructured":"Tisell M, Tullberg M, Mansson JE, Fredman P, Blennow K, Wikkelso C: Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus. Eur J Neurol. 2004, 11: 17-23. 10.1046\/j.1351-5101.2003.00698.x.","journal-title":"Eur J Neurol"},{"key":"34_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3171\/2011.2.JNS101316","volume":"115","author":"A Tarnaris","year":"2011","unstructured":"Tarnaris A, Toma AK, Chapman MD, Keir G, Kitchen ND, Watkins LD: Use of cerebrospinal fluid amyloid-beta and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurosurg. 2011, 115: 145-150. 10.3171\/2011.2.JNS101316.","journal-title":"J Neurosurg"},{"key":"34_CR21","volume-title":"AANS Meeting","author":"J Bauman","year":"2010","unstructured":"Bauman J, Madsen P, Hamilton R, Patel S, Basil A, Jackson EM, Lee EB, Lopinto J, Arnold SE, Clark CM, Shaw LM, Wang X, Xie SX, Trojanowski JQ, Grady MS: Cortical biopsy and empirical post-operative shunt valve programming: a novel treatment approach to idiopathic normal pressure hydrocephalus. AANS Meeting. 2010, Philadelphia, PA, USA"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11064-010-0374-1","volume":"36","author":"A Tarnaris","year":"2011","unstructured":"Tarnaris A, Toma AK, Chapman MD, Petzold A, Keir G, Kitchen ND, Watkins LD: Rostrocaudal dynamics of CSF biomarkers. Neurochem Res. 2011, 36: 528-532. 10.1007\/s11064-010-0374-1.","journal-title":"Neurochem Res"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2045-8118-9-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T01:20:37Z","timestamp":1713748837000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/2045-8118-9-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1186\/2045-8118-9-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]},"assertion":[{"value":"23 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}